Greenwich LifeSciences, Inc. Profile Avatar - Palmy Investing

Greenwich LifeSciences, Inc.

Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which h…

Biotechnology
US, Stafford [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Greenwich LifeSciences, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Greenwich LifeSciences, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Greenwich LifeSciences, Inc..

End of GLSI's Analysis
CIK: 1799788 CUSIP: 396879108 ISIN: US3968791083 LEI: - UEI: -
Secondary Listings
GLSI has no secondary listings inside our databases.